Murakami, H., Yamanaka, T., Seto, T., Sugio, K., Okamoto, I., Sawa, T., . . . Yamamoto, N. (2014). Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group. Cancer Sci.
Chicago Style CitationMurakami, Haruyasu, et al. "Phase II Study of Zoledronic Acid Combined With Docetaxel for Non-small-cell Lung Cancer: West Japan Oncology Group." Cancer Sci 2014.
Cita MLAMurakami, Haruyasu, et al. "Phase II Study of Zoledronic Acid Combined With Docetaxel for Non-small-cell Lung Cancer: West Japan Oncology Group." Cancer Sci 2014.
Atenció: Aquestes cites poden no estar 100% correctes.